How many insider declarations has Shantharam Harish filed?

Shantharam Harish has filed 3 public insider declarations with SEC (Form 4).

What is Shantharam Harish's role?

Shantharam Harish's reported role is not specified by the regulator across the filings.

Which companies does Shantharam Harish report trades for?

Shantharam Harish reports trades for 2 companies, including CymaBay Therapeutics, Inc..

What is Shantharam Harish's declared buy vs sell volume?

Across the available history, declared buys total 50k€ and disposals 0.

← Executives ★ Sign in to follow

SH

Shantharam Harish

CFO

·SEC (Form 4)

CymaBay Therapeutics, Inc.ALX Oncology Holdings INC

0

Total declarations

0

Companies

€50,052

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+42.7%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Shantharam Harish. Insider active across 2 companies, notably CymaBay Therapeutics, Inc.. In total, 3 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €50k. Activity tracked since 24 January 2024. The latest transaction was filed on 18 August 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Shantharam Harish

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

CymaBay Therapeutics, Inc. (US)ALX Oncology Holdings INC (US)

Declarations3 total

▲

Shantharam Harish

Chief Financial OfficerExecutives18 Aug 2025ALX Oncology Holdings INC

$58,40331SEC ↗

75,000 shares@ US$0.7787100.0% of flowCommon StockSEC:0000950170-25-110434:0

Canonical exit: 16 Nov 2025 (T+90)

●

Shantharam Harish

Chief Financial OfficerExecutives22 Mar 2024CymaBay Therapeutics, Inc.

0SEC ↗

20,125 sharesCommon StockSEC:0000950170-24-035460:0

◆

Shantharam Harish

Chief Financial OfficerExecutives24 Jan 2024CymaBay Therapeutics, Inc.

0SEC ↗

20,125 shares0Common StockSEC:0001062993-24-001435:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

SH

Shantharam Harish

CFO

·SEC (Form 4)

CymaBay Therapeutics, Inc.ALX Oncology Holdings INC

0

Total declarations

0

Companies

€50,052

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+42.7%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Shantharam Harish. Insider active across 2 companies, notably CymaBay Therapeutics, Inc.. In total, 3 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €50k. Activity tracked since 24 January 2024. The latest transaction was filed on 18 August 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.